Over nine weeks, semaglutide led to reductions in some measures of weekly alcohol consumption and significantly reduced weekly alcohol craving relative to placebo
This article examines the current evidence, explores alternative explanations for cognitive changes during treatment, and provides guidance on when to seek medical advice
Some people consider DIY at-home kits, but choosing a professional medical spa ensures that your wellness journey is handled with clinical precision
Precise and individualized planning will be essential, doctors agree
What the Trials Have Actually Shown So Far A phase 2 trial published in the New England Journal of Medicine found that 48 weeks of treatment with retatrutide, an agonist of the GIP, GLP-1, and glucagon receptors, produced substantial reductions in body weight among participants with obesity